Inhibition of Chondrosarcoma Growth by mTOR Inhibitor in an In Vivo Syngeneic Rat Model

Targeting the mammalian target of rapamycin in myxoid chondrosarcoma

(2010) Ofer Merimsky et al.   ANTI-CANCER DRUGS

The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapy

(2010) Stephen L. Abrams et al.   CELL CYCLE

Clinical Activity of mTOR Inhibition With Sirolimus in Malignant Perivascular Epithelioid Cell Tumors: Targeting the Pathogenic Activation of mTORC1 in Tumors

(2010) Andrew J. Wagner et al.   JOURNAL OF CLINICAL ONCOLOGY

Inhibition of Tumor Growth Progression by Antiandrogens and mTOR Inhibitor in a Pten-Deficient Mouse Model of Prostate Cancer

(2009) W. Zhang et al.   CANCER RESEARCH

A Phase I Study of the Mammalian Target of Rapamycin Inhibitor Sirolimus and MEC Chemotherapy in Relapsed and Refractory Acute Myelogenous Leukemia

(2009) A. E. Perl et al.   CLINICAL CANCER RESEARCH

Targeted Inhibition of Mammalian Target of Rapamycin Signaling Inhibits Tumorigenesis of Colorectal Cancer

(2009) P. Gulhati et al.   CLINICAL CANCER RESEARCH

Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy

(2009) RuiRong Yuan et al.   Journal of Hematology & Oncology

Heterogeneity of angiogenesis and blood vessel maturation in cartilage tumors

(2009) Thomas Kalinski et al.   PATHOLOGY RESEARCH AND PRACTICE

Inhibition of mTOR pathway by everolimus cooperates with EGFR inhibitors in human tumours sensitive and resistant to anti-EGFR drugs

(2008) R Bianco et al.   BRITISH JOURNAL OF CANCER

The role of mTOR in the management of solid tumors: An overview

(2008) Alex S. Strimpakos et al.   CANCER TREATMENT REVIEWS

Inhibition of mTOR in combination with doxorubicin in an experimental model of hepatocellular carcinoma

(2008) Anne-Christine Piguet et al.   JOURNAL OF HEPATOLOGY

Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy

(2008) J A McCubrey et al.   LEUKEMIA

The Clinical Approach Towards Chondrosarcoma

(2008) H. Gelderblom et al.   ONCOLOGIST